Abstract
Studies were conducted on dogs to test the efficacy of cyclosporin A (CyA) in prolonging normoglycaemia and graft survival after whole-organ pancreas allograft transplantation. Five dogs subjected to pancreatectomy alone served as controls. Withholding immunosuppression after transplantation (five animals) resulted in the same median duration of survival as occurred in the controls (13 days). Azathioprine and steroids (seven animals) produced median durations of normoglycaemia and survival of 9 and 23 days respectively. Animals given CyA 18 mg/kg/day (five) and 25 mg/kg/day (10), however, showed median durations of normoglycaemia of 18 and 55 days (p less than 0.05 and p less than 0.02) respectively and median survival times of 36 and 85 days (NS and p less than 0.02). If CyA proved effective in controlling rejection of pancreas allografts in man it would offer unstable diabetics in renal failure a more hopeful outlook than conventional immunosuppression.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Borel J. F., Feurer C., Gubler H. U., Stähelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions. 1976 Jul;6(4):468–475. doi: 10.1007/BF01973261. [DOI] [PubMed] [Google Scholar]
- Calne R. Y., White D. J., Pentlow B. D., Rolles K., Syrakos T., Ohtawa T., Smith D. P., McMaster P., Evans D. B., Herbertson B. M. Cyclosporin A: preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants. Transplant Proc. 1979 Mar;11(1):860–864. [PubMed] [Google Scholar]
- MARKS H. H. LONGEVITY AND MORTALITY OF DIABETICS. Am J Public Health Nations Health. 1965 Mar;55:416–423. doi: 10.2105/ajph.55.3.416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Najarian J. S., Sutherland D. E., Matas A. J., Goetz F. C. Human islet autotransplantation following pancreatectomy. Transplant Proc. 1979 Mar;11(1):336–340. [PubMed] [Google Scholar]
- Renal transplantation in insulin-dependent diabetics. A joint Scandinavian report. Lancet. 1978 Oct 28;2(8096):915–917. [PubMed] [Google Scholar]